Kohn L D, Winand R J
J Biol Chem. 1975 Aug 25;250(16):6503-8.
Previously reported experiments (Winand, R.J., and Kohn, L.D. (1970) J. Biol. Chem. 245, 967-975; Kohn, L.D., and Winand, R.J. (1971) J. Biol. Chem 246, 6570-6575) have demonstrated that partial pepsin digestion of bovine thyrotropin preparation yields a fragment of the thyrotropin molecule which is exophthalmogenic but has negligible or no thyroid-stimulating activity. In the present report this exophthalmogenic derivative of the thyrotropin molecule is shown to contain two major polypeptide components with approximate molecular weights of 14,000 and 6,000. Amino acid analyses, carbohydrate analyses, and tryptic digestion experiments indicate that this exophthalmogenic factor is composed of an intact or nearly intact beta subunit of thyrotropin and an NH2-terminal fragment of the alpha subunit of thyrotropin. Neither polypeptide component of the exophthalmogenic factor has the in vivo exophthalmogenic activity of the intact structure. In vitro the intact exophthalmogenic derivative of the thyrotropin molecule can bind to the thyrotropin receptor on thyroid membranes less efficiently than thyrotropin but significantly better than either its own polypeptide components or the alpha or beta subunits of thyrotropin. The exophthalmogenic factor and its parent thyrotropin molecule can stimulate adenylate cyclase activity in retro-orbital tissue membranes from guinea pigs, a mammalian model of exophthalmos; its polypeptide components have little or no such activity.
先前报道的实验(维南德,R.J.,和科恩,L.D.(1970年)《生物化学杂志》245卷,967 - 975页;科恩,L.D.,和维南德,R.J.(1971年)《生物化学杂志》246卷,6570 - 6575页)已证明,对牛促甲状腺素制剂进行部分胃蛋白酶消化会产生促甲状腺素分子的一个片段,该片段具有致突眼活性,但甲状腺刺激活性可忽略不计或无此活性。在本报告中,促甲状腺素分子的这种致突眼衍生物显示含有两个主要多肽组分,其近似分子量分别为14,000和6,000。氨基酸分析、碳水化合物分析和胰蛋白酶消化实验表明,这种致突眼因子由促甲状腺素的一个完整或近乎完整的β亚基以及促甲状腺素α亚基的一个NH2 - 末端片段组成。致突眼因子的两个多肽组分均不具有完整结构在体内的致突眼活性。在体外,促甲状腺素分子的完整致突眼衍生物与甲状腺膜上的促甲状腺素受体结合的效率低于促甲状腺素,但明显优于其自身的多肽组分或促甲状腺素的α或β亚基。致突眼因子及其母体促甲状腺素分子可刺激豚鼠眼眶后组织膜中的腺苷酸环化酶活性,豚鼠是突眼症的一种哺乳动物模型;其多肽组分几乎没有或完全没有这种活性。